EMERGENT BIOSOLUTIONS INC. AND EACH OF THE GUARANTORS FROM TIME TO TIME PARTY HERETO 3.875% SENIOR UNSECURED NOTES DUE 2028 INDENTURE Dated as of August 7, 2020 U.S. BANK NATIONAL ASSOCIATION, as TrusteeIndenture • August 7th, 2020 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
INDENTURE dated as of August 7, 2020 among Emergent BioSolutions Inc., a Delaware corporation (the “Company”), the Guarantors (as defined below) from time to time party hereto and U.S. Bank National Association, as trustee (the “Trustee”).
EMERGENT BIOSOLUTIONS INC. 3.875% Senior Unsecured Notes due 2028 PURCHASE AGREEMENT Dated: August 4, 2020Purchase Agreement • August 7th, 2020 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • August 7th, 2020 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of August 7, 2020, among EMERGENT BIOSOLUTIONS INC., a Delaware corporation (the “Borrower”), the Guarantors (as defined in the Credit Agreement referred to below) party hereto, the Lenders party hereto (the “Consenting Lenders”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as administrative agent (the “Administrative Agent”). Unless otherwise indicated, all capitalized terms used herein and not otherwise defined herein shall have the respective meanings provided such terms in the Credit Agreement referred to below.
